Impaired fasting glucose and silent myocardial ischemia;Nieprawidłowa tolerancja glukozy a nieme niedokrwienie miȩśnia sercowego

Polskie Archiwum Medycyny Wewnetrznej

Volumn 114, Issue 5, 2005, Pages 1066-1071

  Kokot, Teresa ^a   Nowakowska Zajdel, Ewa ^a   Muc Wierzgoń, Małgorzata ^a   Brodziak, Andrzej ^a   Poprawa, Beata ^a   Kozowicz, Andrzej ^a   Wojtas, Andrzej ^a  

^a Katedra I Oddział Kliniczny Chorób Wewnȩtrznych Śl AM W Bytomiu ^*

Author keywords

IGF; Silent ischemia

Indexed keywords

ARTICLE; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HEART PERFUSION; HUMAN; INCIDENCE; SILENT MYOCARDIAL ISCHEMIA; SYMPTOMATOLOGY;

EID: 33645993845     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Witek P.: Nieme niedokrwienie miȩśnia sercowego. Przegl. Lek., 2001, 58, 127.
2. Kuch J., Mamcarz A.: Nieme niedokrwienie. Przyczynek do etiopatogenezy, kliniki, rozpoznania i prognozowania. Klinika, 2001, 4, 489.
3. Cohn P.F.: Silent myocardial ischemia. Ann. Intern. Med., 1988, 109, 312.
4. Wilson P.W.: Established risk factors and coronary artery disease: the Framingham Study. Am. J. Hypertens., 1994, 7, 7S.
5. Janand-Delenne B., Savin B., Habib G. i wsp: Silent myocardial ischemia in patients with diabetes. Diabetes Care, 1999, 22, 1396.
6. Hanefeld M., Temelkova-Kurktschiev T.: Control of post-prandial hyperglycemia - an essential part of good diabetes treatment and prevention of cardiovascular complications. Nutr. Metab. Cardiovasc. Dis., 2002, 12, 98.
7. KuusistoJ., Mykkanen L., Pyorala K.: NIDDM and its metabolit control predict coronary hart disease in the elderly subjects. Diabetes, 1994, 43, 960.
8. Pailloe C., Ruiz J., Juliard J.M. i wsp: Detection of coronary artery disease in diabetic patients. Diabetologia, 1995, 38, 726.
9. Tominaga M., Eguchi H., Manaka H. i wsp.: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose the Funagata Diabetes Study. Diabetes Care, 1999, 22, 920.
10. DECODE Study Group Glucose intolerance and mortality: comparison of WHO and American Diabetes Association criteria. Lancet, 1999, 354, 617.
11. Hu F.B.: Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care, 2002, 25, 1129.
12. Inoguchi T., Yamashita T., Umeda F. i wsp.: High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus. Diabetes Res. and Clin. Practice, 2000, 47, 37.
13. Grundy S.M., Banjamin I.J., Burke G.L. i wsp.: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation, 1999, 100, 1134.
14. Lubaszewski W., Kawecka-Jaszcz K., Czamecka D. i wsp.: Nieme niedokrwienie miȩśnia serca u chorych z nadciśnieniem tȩtniczym. Kardiol. Pol., 1998, 48, 121.
15. Baron A.D.: Impaired glucose tolerance as a disease. Am. J. Cardiol., 2001, 88, 16H.
16. Liao D., Szofer J.B., Boyko E.J. i wsp.: Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose. Diabetes Care, 2001, 24, 39.